Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope.
about
Novel Identified HLA-A*0201-Restricted Hantaan Virus Glycoprotein Cytotoxic T-Cell Epitopes Could Effectively Induce Protective Responses in HLA-A2.1/Kb Transgenic Mice May Associate with the Severity of Hemorrhagic Fever with Renal Syndrome.Novel Strategies for Peptide-Based Vaccines in Hematological MalignanciesNext Generation Cancer Vaccines-Make It Personal!
P2860
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Vaccination of stage III/IV me ...... novel DR7-restricted epitope.
@en
type
label
Vaccination of stage III/IV me ...... novel DR7-restricted epitope.
@en
prefLabel
Vaccination of stage III/IV me ...... novel DR7-restricted epitope.
@en
P2093
P2860
P50
P1433
P1476
Vaccination of stage III/IV me ...... a novel DR7-restricted epitope
@en
P2093
C Costa Nunes
D E Speiser
H Maby-El Hajjami
J-P Rivals
O Michielin
P2860
P304
P356
10.1080/2162402X.2016.1216290
P577
2016-09-09T00:00:00Z